Mirna Fernández

Mirna Fernández

Auto-generated profile, based on publicly available information

Mirna Fernández

Instituto de Farmacia y Alimentos. Universidad de La Habana

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
NPNilia de la Paz
Nilia de la Paz
MFMirna Fernández
Mirna Fernández
Orestes LópezOrestes López
Orestes López
CGCaridad Garcia
Caridad Garcia
ANAntonio Nogueira
Antonio Nogueira
Jyrki HeinämäkiJyrki Heinämäki
Jyrki Heinämäki
We investigated a spray drying process for preparing water-soluble salts of high molecular weight chitosan (CH) intended for pharmaceutical excipient applications. CH was derived from chitin of marine lobster origin (Panulirus argus). The effects of organic acid (acetic or lactic acid) and the ratio (difference) of inlet/outlet air temperature (140/90 °C or 160/100 °C) on spray drying were studied. The yield of spray-dried CH salt powders ranged from 50% to 99% in laboratory and industrial-scale processes. The spray-dried dry powder of CH salts consisted of spherical agglomerated particles with an average diameter of 36.2 ± 7.0 µm (CH acetate) and 108.6 ± 11.5 µm (CH lactate). After dispersing the spray-dried CH salt powder samples in purified water, the mean particle sizes obtained for the CH acetate salts were 31.4 nm (batch A001), 33.0 nm (A002) and 44.2 nm (A003), and for the CH lactate salts 100.8 nm (batch L001), 103.2 nm (L002) and 121.8 nm (L003). The optimum process conditions for spray drying were found: an inlet air temperature of 160 ± 5 °C, an outlet temperature of 100 ± 5 °C and an atomizer disk rotational speed of 18,200 min−1. The X-ray powder diffraction (XRPD) and differential scanning calorimetry (DSC) results confirmed the amorphous state of the CH salts. The 1H nuclear magnetic resonance (NMR) and Fourier transform infrared (FT-IR) spectra of CH acetate and lactate salts verified that the spray drying process does not affect the polymer backbone. In conclusion, both laboratory and industrial-scale spray drying methods for preparing water-soluble acid salts of CH are reproducible, and the physicochemical properties of the corresponding CH acid salts are uniform.

10 March 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CMClaudia Miranda
Claudia Miranda
AAAlexis Aceituno
Alexis Aceituno
MFMirna Fernández
Mirna Fernández
GMGustavo Mendes
Gustavo Mendes
YRYanina Rodriguez
Yanina Rodriguez
Miguel Angel Cabrera-PerezMiguel Angel Cabrera-Perez
Miguel Angel Cabrera-Perez
The biopharmaceutical classification system (BCS) is a very important tool to replace the traditional in vivo bioequivalence studies with in vitro dissolution assays during multisource product development. This paper compares the most recent harmonized guideline for biowaivers based on the biopharmaceutics classification system and the BCS regulatory guidelines in Latin America and analyzes the current BCS regulatory requirements and the perspective of the harmonization in the region to develop safe and effective multisource products. Differences and similarities between the official and publicly available BCS guidelines of several Latin American regulatory authorities and the new ICH harmonization guideline were identified and compared. Only Chile, Brazil, Colombia, and Argentina have a more comprehensive BCS guideline, which includes solubility, permeability, and dissolution requirements. Although their regulatory documents have many similarities with the ICH guidelines, there are still major differences in their interpretation and application. This situation is an obstacle to the successful development of safe and effective multisource products in the Latin American region, not only to improve their access to patients at a reasonable cost, but also to develop BCS biowaiver studies that fulfill the quality standards of regulators in developed and emerging markets.

1 January 2018 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Closed access
CGCaridad M. García
Caridad M. García
MFMirna Fernández
Mirna Fernández
OLOrestes D. López
Orestes D. López
LDLivan Delgado-Roche
Livan Delgado-Roche
ANAntonio Nogueira
Antonio Nogueira
EMEsteban A. Medrano
Esteban A. Medrano
Context: Spray-drying is a technique used to produce encapsulated products, thus improving the stability of components as well as their organoleptic characteristics. Aims: To evaluate the effect of microencapsulation of shark liver oil pool by spray drying on its physical-chemical properties and antioxidant capacity. Methods: A mix design was created with a constant load of oil, made possible by controlling the proportion between chitosan acetate and maltodextrin. Loss on drying, encapsulation efficiency and yield were determined for the microcapsules. Reversed-phase HPLC analysis was used in order to determine the vitamin A content in microencapsulated and non-microencapsulated oil, as well as its delivery from the dried product. Vitamin A was the active compound used as a chemical marker. The following parameters were also evaluated: organoleptic characteristics, moisture content, particle size, surface morphology and antioxidant capacity. Results: The encapsulation efficiency of microencapsulated oil increased slightly as the concentration of chitosan acetate increased. In order to achieve a greater encapsulation efficiency and a lower moisture content in microencapsulated oil, the proportion between chitosan acetate and maltodextrin should be maintained at 35% and 35% each, according to established manufacturing conditions. Both polymers prevent oil from leaving the droplet. This is a very important factor in storage stability of vitamins and fatty acids, which are subject to oxidative deterioration. Conclusions: Spray-drying microencapsulation of pool oil does not affect vitamin A content or delivery; fatty acid content and antioxidant capacity are also not affected.

1 December 2015 in Ars Pharmaceutica (Internet)
Verified
Journal Article
Closed access
PDF file
NPNilia De la Paz
Nilia De la Paz
CGCaridad García
Caridad García
MFMirna Fernández
Mirna Fernández
LGLisandra García
Lisandra García
VMVivian Martínez
Vivian Martínez
ANAntonio Nogueira
Antonio Nogueira

1 January 2019 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Closed access
DPDania Pérez
Dania Pérez
NPNilia de la Paz
Nilia de la Paz
MFMirna Fernández
Mirna Fernández
NMNiurys Mantilla
Niurys Mantilla
MPMariela Peña
Mariela Peña
AMAddis Menéndez
Addis Menéndez
Context: Chitosan has received attention as a functional, sustainably renewable, nontoxic and biodegradable biopolymer for pharmaceutical applications such as healing agent. Aims: To design a semisolid pharmaceutical form (ointment), employing 1% chitosan as an active pharmaceutical ingredient. Methods: The formulation was carried out through D-optimal mixing design, with a linear model. Variation components evaluated were the concentration of sodium hydroxide, water and anhydrous lanolin. Variables included those of response pH and extensibility. Three batches were produced, and the physical and chemical stability of the ointment was assessed through stress and shelf-life tests for 24 months. Physical-chemical parameters studied included organoleptic characteristics, chitosan content, rheological behavior, apparent viscosity, pH and extensibility. Wound healing activity was also tested for burns damage model in rats. Results: The mixture design showed that the best formulation was the one containing 0.12% sodium hydroxide, 20.0% anhydrous lanolin and 40.0% water, with the mechanical-structural behavior characteristics of a semisolid product. This product had healing effects and showed adequate physical chemical stability during the time under study. Conclusions: The results of this study suggest that 1% chitosan ointment design favors scarring in the second-degree burn damage model in rats skin applied for 14 days at the rate of daily administration.

1 March 2021 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Open access
CPCaridad M. García Peña
Caridad M. García Peña
MCMirna Fernández Cervera
Mirna Fernández Cervera
MDMirta Castiñeira Díaz
Mirta Castiñeira Díaz
OHOrestes D. López Hernández
Orestes D. López Hernández
VEVivian Martínez Espinosa
Vivian Martínez Espinosa
AMAntonio Nogueira Mendoza
Antonio Nogueira Mendoza
Https://jppres.com/jppres/aceite-de-higado-de-tiburon-microencapsulado/#:~:text=Context%3A%20The%20recognized%20properties,stability%2C%20for%2024%20months.